Dose-reduced trastuzumab deruxtecan can be safely used in liver failure and active leptomeningeal metastases
{{output}}
Trastuzumab deruxtecan has been shown to have responses in heavily pretreated patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer. However, the safety of this medication in patients with severe liver dysfunction and ... ...
